central retinal vein occlusion
Information
- Disease name
- central retinal vein occlusion
- Disease ID
- DOID:2450
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04793100 | Active, not recruiting | N/A | Spontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections | March 24, 2021 | March 23, 2025 |
| NCT00406796 | Completed | Phase 1 | Lucentis for Central Retinal Vein Occlusion (CRVO) | January 2006 | October 2010 |
| NCT02390245 | Completed | N/A | Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study | September 2014 | August 2020 |
| NCT00952614 | Completed | N/A | A Study of a Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion | October 2002 | May 2009 |
| NCT01028248 | Completed | Phase 1 | Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion | January 2010 | June 2013 |
| NCT01231633 | Completed | N/A | Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) | September 2010 | September 2014 |
| NCT01360385 | Completed | Retinal Ischemia in Central Retinal Vein Occlusion, and the Effects of Treatment With Intravitreal Ranibizumab | October 2010 | July 2012 | |
| NCT01396083 | Completed | Phase 3 | Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) | August 2011 | January 2014 |
| NCT01448018 | Completed | Phase 4 | Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion | January 2010 | December 2013 |
| NCT01471691 | Completed | Phase 1/Phase 2 | Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab | November 2011 | February 2014 |
| NCT01535261 | Completed | Phase 3 | Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion | February 2012 | March 2015 |
| NCT01581411 | Completed | Phase 1 | Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion | January 2012 | November 2015 |
| NCT01640171 | Completed | N/A | Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival | July 2012 | October 2013 |
| NCT01724554 | Completed | Phase 1/Phase 2 | Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion | November 2012 | October 2014 |
| NCT01793181 | Completed | Vitamin D Levels in Patients With Central Retinal Vein Occlusion- a Prospective Controlled Study | January 2013 | November 2014 | |
| NCT01969708 | Completed | Phase 3 | Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) | September 2014 | March 2021 |
| NCT01976312 | Completed | Phase 3 | Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO) | November 12, 2013 | March 14, 2016 |
| NCT02274259 | Completed | Phase 4 | Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen | October 2014 | December 2016 |
| NCT02503540 | Completed | Phase 4 | Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO | August 18, 2015 | February 6, 2018 |
| NCT02747030 | Completed | Phase 1 | Phase I RVC With Ocriplasmin for CRVO | December 2016 | August 11, 2017 |
| NCT02800642 | Completed | Phase 4 | Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO | June 10, 2016 | July 31, 2019 |
| NCT03223714 | Completed | Phase 3 | Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion | May 24, 2016 | September 28, 2020 |
| NCT03981549 | Completed | Phase 1/Phase 2 | Treatment of Central Retinal Vein Occlusion Using Stem Cells Study | October 22, 2019 | February 6, 2024 |
| NCT04740931 | Completed | Phase 3 | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion | March 2, 2021 | July 12, 2023 |
| NCT00532142 | Completed | Phase 2/Phase 3 | The ROVO Study: Radial Optic Neurotomy for CVO | April 2005 | August 2009 |
| NCT00556114 | Completed | A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging | January 2007 | July 2013 | |
| NCT00567697 | Completed | Phase 3 | A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO | March 2007 | October 2008 |
| NCT00906685 | Completed | Phase 3 | Bevacizumab for Central Retinal Vein Occlusion Study | May 2009 | September 2011 |
| NCT00500045 | Terminated | Phase 2/Phase 3 | Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions | February 2007 | October 2016 |
| NCT03810313 | Terminated | Phase 3 | Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion | July 3, 2019 | July 26, 2021 |
| NCT00566761 | Terminated | Phase 4 | Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO | June 2007 | March 2008 |
| NCT00969293 | Terminated | Phase 1 | Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion | September 2009 | March 2012 |
| NCT00211471 | Terminated | Phase 2 | Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.). | March 2002 | May 2007 |
| NCT01011374 | Unknown status | Phase 1 | Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion | November 2009 | November 2013 |
| NCT01178697 | Unknown status | Phase 2 | Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO) | January 2010 | December 2010 |
| NCT04601701 | Unknown status | N/A | Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only. | October 17, 2020 | September 17, 2021 |
| NCT01303276 | Unknown status | Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion (CRVO) | June 2011 | ||
| NCT01348633 | Unknown status | Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye | March 2012 | August 2015 | |
| NCT04667910 | Unknown status | Phase 2 | 601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO) | December 2020 | January 2023 |
| NCT02091505 | Unknown status | N/A | Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO | December 2013 | |
| NCT02169648 | Unknown status | N/A | Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion | December 2013 | December 2015 |
| NCT02173873 | Unknown status | Phase 1 | Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I | June 2014 | December 2016 |
| NCT01531842 | Unknown status | N/A | A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye | August 2011 | August 2013 |
| NCT01827722 | Unknown status | Phase 4 | Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion | May 2013 | December 2016 |
| NCT00517257 | Unknown status | Phase 3 | Atorvastatin for the Treatment of Retinal Vein Occlusion | August 2007 | September 2009 |
| NCT02405741 | Unknown status | Phase 2 | Hyperbaric Chamber for Central Retinal Vein Occlusion (CRVO) Patients | March 2015 | September 2016 |
| NCT01678248 | Unknown status | The Effectiveness of Intravitreal Avastin Injection for CRVO | January 2006 | ||
| NCT00383773 | Unknown status | N/A | Retinal Endo Vascular Surgery for Central Retinal Vein Occlusion | October 2006 | October 2007 |
| NCT03417401 | Withdrawn | Phase 1 | Surgical Stabilizer Assisted RVC With rtPA for CRVO | October 16, 2018 | December 10, 2021 |
- Disase is a (Disease Ontology)
- DOID:1727
- Cross Reference ID (Disease Ontology)
- ICD10CM:H34.81
- Cross Reference ID (Disease Ontology)
- ICD9CM:362.35
- Cross Reference ID (Disease Ontology)
- MESH:D012170
- Cross Reference ID (Disease Ontology)
- NCI:C118859
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:193378003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0154841
- MedGen concept unique identifier (MedGen Concept name)
- C0154841
- MedGen unique identifier (MedGen Concept name)
- 509679